|
US5217879A
(en)
|
1989-01-12 |
1993-06-08 |
Washington University |
Infectious Sindbis virus vectors
|
|
EP0819250B1
(en)
|
1995-04-06 |
2006-09-20 |
Miltenyi Biotec Inc. |
Multiparameter cell separation using releasable colloidal magnetic particles
|
|
US6451592B1
(en)
|
1996-04-05 |
2002-09-17 |
Chiron Corporation |
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
|
|
US6465634B1
(en)
|
1996-04-05 |
2002-10-15 |
Chiron Corporation |
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
|
|
WO1999050432A1
(en)
*
|
1998-03-27 |
1999-10-07 |
Cytos Biotechnology Ag |
Inducible alphaviral gene expression system
|
|
HK1038929B
(zh)
|
1998-07-31 |
2005-05-06 |
株式会社国际癌症免疫研究所 |
基於癌抑制基因wt1的产物的癌抗原
|
|
DK1175497T3
(da)
|
1999-04-14 |
2010-05-31 |
Novartis Vaccines & Diagnostic |
Præparater og fremgangsmåder til generering af et immunrespons ved udnyttelse af alfavirusbaserede vektorsystemer
|
|
US8647864B2
(en)
|
1999-04-14 |
2014-02-11 |
Novartis Ag |
Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
|
|
ATE367445T1
(de)
|
1999-05-18 |
2007-08-15 |
Dnavec Research Inc |
Viraler paramyxoviridae vektor mit einem defekten hüllprotein-gen
|
|
AU2002303330B2
(en)
|
2001-05-31 |
2008-07-24 |
Novartis Vaccines And Diagnostics, Inc. |
Chimeric alphavirus replicon particles
|
|
US20030232324A1
(en)
|
2001-05-31 |
2003-12-18 |
Chiron Corporation |
Chimeric alphavirus replicon particles
|
|
US7045335B2
(en)
|
2001-09-06 |
2006-05-16 |
Alphavax, Inc. |
Alphavirus replicon vector systems
|
|
MXPA05001644A
(es)
|
2002-08-13 |
2005-04-19 |
Akzo Nobel Nv |
Replicones de pestivirus que no expresan proteina c y/o e1, y particulas virales infecciosas que los contienen y pueden usarse en vacunas.
|
|
AU2003270824B2
(en)
*
|
2002-09-18 |
2009-02-19 |
The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
|
|
US6943015B2
(en)
|
2002-12-12 |
2005-09-13 |
Ilya Frolov |
Large scale production of packaged alphavirus replicons
|
|
JP5079981B2
(ja)
|
2002-12-13 |
2012-11-21 |
アルファバックス，インコーポレイティド |
アルファウイルス粒子及び調製方法
|
|
KR101518309B1
(ko)
|
2003-03-20 |
2015-05-08 |
알파벡스, 인크. |
개선된 알파바이러스 레플리콘 및 헬퍼 구축물
|
|
US20050282279A1
(en)
*
|
2003-05-29 |
2005-12-22 |
Hwu Paul L |
Expression vector encoding coronavirus-like particle
|
|
EP1629104A4
(en)
*
|
2003-06-04 |
2006-11-02 |
Bioleaders Corp |
CELL SURFACE EXPRESSION VECTOR OF SARS VIRUS ANTIGEN AND TRANSFORMED MICROORGANISMS
|
|
SI1629004T1
(sl)
|
2003-06-05 |
2008-12-31 |
Wyeth Corp |
Imunogeni sestavki, ki vsebujejo vektorski replikon virusa venezuelskega konjskega encefalitisa in antigen za protein paramiksovirusa
|
|
ES2321212T3
(es)
|
2004-05-18 |
2009-06-03 |
Alphavax, Inc. |
Vectores alfavirus derivados de tc-83, particulas y metodos antecentes de la invencion.
|
|
US7332322B2
(en)
|
2004-09-14 |
2008-02-19 |
Ilya Frolov |
Venezuelan equine encephalitis virus replicons with adaptive mutations in the genome and uses thereof
|
|
US7998733B2
(en)
*
|
2004-10-05 |
2011-08-16 |
Merial Limited |
Chimeric vectors
|
|
JP4478788B2
(ja)
|
2005-05-27 |
2010-06-09 |
独立行政法人産業技術総合研究所 |
センダイウイルス温度感受性株由来のウイルスベクター
|
|
HUE043492T2
(hu)
|
2005-08-23 |
2019-08-28 |
Univ Pennsylvania |
Módosított nukleozidokat tartalmazó RNS és eljárások az alkalmazására
|
|
CA2626238C
(en)
|
2005-10-17 |
2015-10-06 |
Memorial Sloan Kettering Cancer Center |
Wt1 hla class ii-binding peptides and compositions and methods comprising same
|
|
AP2008004629A0
(en)
|
2006-02-27 |
2008-10-31 |
Univ Texas |
Pseudoinfectious flavivirus and uses thereof
|
|
CA2668417A1
(en)
|
2006-11-03 |
2008-05-15 |
Alphavax, Inc. |
Alphavirus and alphavirus replicon particle formulations and methods
|
|
PL2119778T3
(pl)
|
2007-02-27 |
2016-04-29 |
Int Inst Cancer Immunology Inc |
Sposób aktywacji pomocniczej komórki T oraz kompozycja do zastosowania w tym sposobie
|
|
US8748591B2
(en)
|
2007-04-17 |
2014-06-10 |
The Board Of Regents Of The University Of Texas System |
Chimeric sindbis-western equine encephalitis virus and uses thereof
|
|
US20100203027A1
(en)
*
|
2007-04-27 |
2010-08-12 |
Kyushu Univeristy National University |
Viral vector for gene therapy
|
|
WO2009079185A2
(en)
*
|
2007-11-26 |
2009-06-25 |
Novartis Vaccines And Diagnostics, Inc. |
Methods of generating alphavirus particles
|
|
JP5478260B2
(ja)
|
2007-12-05 |
2014-04-23 |
株式会社癌免疫研究所 |
癌ワクチン組成物
|
|
CN102083986B
(zh)
|
2008-01-24 |
2014-06-18 |
德克萨斯大学系统董事会 |
不能在蚊子中复制的减毒重组甲病毒及其用途
|
|
EP2130912A1
(en)
|
2008-06-04 |
2009-12-09 |
Institut für Viruskrankeiten und Immunprophylaxe |
Pestivirus replicons providing an RNA-based viral vector system
|
|
CN102159710B
(zh)
|
2008-07-16 |
2015-09-02 |
生物载体株式会社 |
使用染色体非整合型病毒载体制造经初始化的细胞的方法
|
|
EP2451475A2
(en)
|
2009-07-06 |
2012-05-16 |
Novartis AG |
Self replicating rna molecules and uses thereof
|
|
US9770463B2
(en)
|
2010-07-06 |
2017-09-26 |
Glaxosmithkline Biologicals Sa |
Delivery of RNA to different cell types
|
|
EP3520813B1
(en)
|
2010-10-11 |
2023-04-19 |
GlaxoSmithKline Biologicals S.A. |
Antigen delivery platforms
|
|
US9402890B2
(en)
|
2011-02-01 |
2016-08-02 |
Uab Research Foundation |
Methods and compositions for pseudoinfectious alphaviruses
|
|
RU2649133C2
(ru)
*
|
2011-07-06 |
2018-03-29 |
Новартис Аг |
Катионные эмульсии масло-в-воде
|
|
CA2861206C
(en)
|
2012-01-13 |
2021-07-06 |
Richard J. O'reilly |
Immunogenic wt-1 peptides and methods of use thereof
|
|
CA2873964C
(en)
|
2012-05-21 |
2025-09-16 |
The Regents Of The University Of California |
GENERATION OF HUMAN IP CELLS BY SELF-REPLICATING SYNTHETIC RNA
|
|
US8961995B2
(en)
|
2012-09-20 |
2015-02-24 |
Uab Research Foundation |
Methods and compositions for alphavirus replicons
|
|
WO2014089513A1
(en)
|
2012-12-06 |
2014-06-12 |
Synthetic Genomics, Inc. |
Autonomous replication sequences and episomal dna molecules
|
|
US10815273B2
(en)
|
2013-01-15 |
2020-10-27 |
Memorial Sloan Kettering Cancer Center |
Immunogenic WT-1 peptides and methods of use thereof
|
|
CN110078813B
(zh)
|
2013-01-15 |
2023-03-28 |
纪念斯隆凯特林癌症中心 |
免疫原性wt-1肽和其使用方法
|
|
KR20160023638A
(ko)
|
2013-02-28 |
2016-03-03 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
줄기세포를 이동하기 위한 방법 및 조성물
|
|
RU2735141C2
(ru)
|
2013-03-15 |
2020-10-28 |
Иликсиэджен Терапьютикс, Инк. |
Способы применения zscan4 для омоложения человеческих клеток
|
|
WO2014200910A2
(en)
|
2013-06-10 |
2014-12-18 |
Iogenetics, Llc |
Bioinformatic processes for determination of peptide binding
|
|
CN105916980B
(zh)
*
|
2013-09-24 |
2025-09-16 |
株式会社爱迪药业 |
用于改进诱导多能干细胞的效率的方法
|
|
CN105829528B
(zh)
*
|
2013-12-20 |
2019-10-22 |
勃林格殷格翰动物保健有限公司 |
PRRS病毒变体、欧洲PRRS病毒cDNA克隆及其用途
|
|
WO2015123592A2
(en)
|
2014-02-13 |
2015-08-20 |
Synthetic Genomics, Inc. |
Recombinant rna particles and methods of use
|
|
US10266834B2
(en)
|
2014-02-13 |
2019-04-23 |
Synthetic Genomics, Inc. |
Recombinant RNA particles and methods of producing proteins
|
|
WO2016125364A1
(ja)
|
2015-02-02 |
2016-08-11 |
株式会社Ｉｄファーマ |
改良されたマイナス鎖ｒｎａウイルスベクター
|
|
EP3061826A1
(en)
|
2015-02-27 |
2016-08-31 |
Novartis AG |
Flavivirus replicons
|
|
CA2986235A1
(en)
*
|
2015-05-20 |
2016-11-24 |
The Broad Institute, Inc. |
Shared neoantigens
|
|
WO2016208332A1
(ja)
|
2015-06-25 |
2016-12-29 |
国立大学法人神戸大学 |
経口腫瘍ワクチン
|
|
WO2017015457A1
(en)
|
2015-07-21 |
2017-01-26 |
Modernatx, Inc. |
Ebola vaccine
|
|
EP3334755B1
(en)
|
2015-08-10 |
2020-04-08 |
Cellivery Therapeutics, Inc. |
Improved cell-permeable reprogramming factor (icp-rf) recombinant protein and use thereof
|
|
US10166281B2
(en)
|
2015-09-04 |
2019-01-01 |
Vlp Therapeutics, Llc |
Method and composition for modulating immune response
|
|
DK3375874T3
(da)
|
2015-11-13 |
2022-05-09 |
Id Pharma Co Ltd |
Forbedret paramyxovirus-vektor
|
|
US10801041B2
(en)
|
2015-11-18 |
2020-10-13 |
Orbis Health Solutions, Llc |
T7 alpha viral vector system
|
|
SMT202200370T1
(it)
|
2015-11-20 |
2022-11-18 |
Memorial Sloan Kettering Cancer Center |
Composizione per il trattamento del cancro
|
|
GB201603374D0
(en)
|
2016-02-26 |
2016-04-13 |
Ucl Business Plc |
Packaging cell
|
|
WO2017162265A1
(en)
|
2016-03-21 |
2017-09-28 |
Biontech Rna Pharmaceuticals Gmbh |
Trans-replicating rna
|
|
WO2017162266A1
(en)
|
2016-03-21 |
2017-09-28 |
Biontech Rna Pharmaceuticals Gmbh |
Rna replicon for versatile and efficient gene expression
|
|
WO2017180770A1
(en)
|
2016-04-13 |
2017-10-19 |
Synthetic Genomics, Inc. |
Recombinant arterivirus replicon systems and uses thereof
|
|
US10967057B2
(en)
|
2016-06-02 |
2021-04-06 |
Glaxosmithkline Biologicals S.A. |
Zika viral antigen constructs
|
|
US20190216956A1
(en)
*
|
2016-07-27 |
2019-07-18 |
The Trustees Of Columbia University In The City Of New York |
Compositions for radiotherapy and uses thereof
|
|
JP7382230B2
(ja)
|
2016-10-17 |
2023-11-16 |
ヤンセン ファーマシューティカルズ，インコーポレーテッド |
組み換えウイルスレプリコン系及びその使用
|
|
WO2018075827A1
(en)
|
2016-10-19 |
2018-04-26 |
Arcturus Therapeutics, Inc. |
Trinucleotide mrna cap analogs
|
|
EP4599847A3
(en)
*
|
2016-10-25 |
2025-11-12 |
Trustees of Dartmouth College |
Prefusion coronavirus spike proteins and their use
|
|
BR112019011661A2
(pt)
|
2016-12-05 |
2020-01-07 |
Synthetic Genomics, Inc. |
Composições e métodos para aumentar expressão de gene
|
|
WO2018115527A2
(en)
|
2016-12-23 |
2018-06-28 |
Curevac Ag |
Mers coronavirus vaccine
|
|
WO2018161092A1
(en)
|
2017-03-03 |
2018-09-07 |
New York University |
Induction and enhancement of antitumor immunity involving virus vectors expressing multiple epitopes of tumor associated antigens and immune checkpoint inhibitors or proteins
|
|
WO2018170347A1
(en)
*
|
2017-03-17 |
2018-09-20 |
Modernatx, Inc. |
Zoonotic disease rna vaccines
|
|
WO2018222890A1
(en)
|
2017-05-31 |
2018-12-06 |
Arcturus Therapeutics, Inc. |
Synthesis and structure of high potency rna therapeutics
|
|
SG11202005792RA
(en)
|
2017-12-20 |
2020-07-29 |
Vlp Therapeutics Llc |
Alphavirus replicon particle
|
|
KR20200111729A
(ko)
|
2018-01-19 |
2020-09-29 |
얀센 파마슈티칼즈, 인코포레이티드 |
재조합 레플리콘 시스템을 이용한 면역 반응 유도 및 증진
|
|
AU2019277361B2
(en)
|
2018-05-30 |
2025-04-24 |
Translate Bio, Inc. |
Messenger RNA vaccines and uses thereof
|
|
WO2021119545A1
(en)
|
2019-12-11 |
2021-06-17 |
Gritstone Bio, Inc. |
Durable vaccination
|
|
KR20220128367A
(ko)
|
2019-12-31 |
2022-09-20 |
엘릭서젠 쎄라퓨틱스, 인크. |
Zscan4 핵산 및 단백질의 세포 및 조직으로의 온도-기반 일시적 전달
|
|
MX2022007905A
(es)
|
2019-12-31 |
2022-08-25 |
Elixirgen Therapeutics Inc |
Administracion transitoria basada en temperatura de acidos nucleicos y proteinas a celulas y tejidos.
|
|
EP4142786A4
(en)
|
2020-04-27 |
2024-06-19 |
Ohio State Innovation Foundation |
LIVE ATTENUATED MEASLES VIRUS VACCINE AGAINST SARS-COV-2
|
|
EP4168042A1
(en)
|
2020-06-19 |
2023-04-26 |
Ziphius Vaccines |
Self-amplifying sars-cov-2 rna vaccine
|